By Daniella Parra Nanox Imaging Ltd. said that its AI Cardiac Solution (HealthCCSng) was showcased at SCCT 2024. Corewell Health’s study showed HealthCCSng identified 3,721 new patients with significant CAC in one year, improving patient outcomes and compliance. Jefferson Einstein...

By Daniella Parra Agilent Technologies (NYSE: A) said it’s acquiring BIOVECTRA, a Canadian CDMO, for $925 million. The company said it will enhance Agilent’s biopharma solutions by expanding service offerings, adding expertise in fast-growing segments like ADCs and HPAPIs, and strengthening...

By Karen Roman The deadline to vote in favor of an $8 billion settlement in a class action lawsuit against Johnson & Johnson (NYSE: JNJ) regarding its talcum powder products is 5pm ET Friday, leaving claimants just hours to act. ...

By Daniella Parra Haystack Oncology and Lisata Therapeutics (Nasdaq: LSTA) are jointly researching the efficacy of a pancreatic cancer therapy, they said. The study will test Lisata’s drug, certepetide, combined with chemotherapy in patients with metastatic pancreatic cancer and Haystack’s...

By Karen Roman Conduit Pharmaceuticals Inc. (Nasdaq: CDT) said IP Australia approved a patent application for an activator targeting autoimmune diseases. This should open the path to approvals in other countries, Conduit said in a statement. “With up to 20...

By Daniella Parra Aktis Oncology said it appointed Akos Czibere, MD, PhD, as Chief Medical Officer. Dr. Czibere has overseen several functional areas in his nearly 20-year career, filed a number of new drug applications and successfully led multiple global...

By Daniella Parra Agilent Technologies, Inc. (NYSE: A) has appointed Bret DiMarco as senior vice president and chief legal officer, also serving as secretary, the company announced Monday. DiMarco, previously the chief legal officer at Pendo.io, has extensive legal and...

By Daniella Parra Sparrow Pharmaceuticals shared data on the combination of clofutriben (SPI-62), an HSD-1 inhibitor, and prednisolone for treating polymyalgia rheumatica (PMR). The company said that HSD-1 inhibition can reduce glucocorticoid side effects while maintaining treatment efficacy and combining...

By Daniella Parra NANO-X IMAGING LTD (Nasdaq: NNOX) has integrated FDA-cleared AI solutions into its Second Opinions online consultation service, offered by its subsidiary, USARAD Holdings INC, the company said. This platform connects patients with specialists for additional diagnostic consultations,...

By Daniella Parra Lisata Therapeutics (Nasdaq: LSTA), said it has fully enrolled the pancreatic cancer cohort for the CENDIFOX trial. The company said it evaluates certepetide with FOLFIRINOX therapies in pancreatic, colon, and appendiceal cancers and the trial is being...